Drug Database
Back to search

Poland· PL-100091241

Ketotifen Hasco

A ketotifen product containing ketotifenum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC R06AX17

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedKetotifen HascoATCR06AX17REGISTER NO.PL-100091241PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ketotifenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ketotifen is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX17 (ketotifen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search ketotifen products by name

Ketotifen · ATC R06AX17

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ketotifen costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ketotifen · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ketotifenum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
R06AX17
ATC class
Ketotifen
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990458813

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for ketotifen.

Graded by severity as the source publishes them — 108 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ketotifen against other medicinesHow interaction checks work

Ketotifen · interactions on record

108 records

  • 108 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Ketotifen in 16 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All ketotifen products

    Authorised across Europe · EMA

    The same active substance is authorised in 24 EEA countries. Names it is sold under:

    • Austria · Ketotifen Stulln, Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln
    • Belgium · Altriabak, Ketazed
    • Bulgaria · Ketotifen Sopharma, Забак
    • Cyprus · Meni-Drops, Tenerel
    • Czechia · Ketof, Ketotifen Al
    • Germany · Allergo-Vision Sine, Ketazed
    • Denmark · Ketazed, Zaditen
    • Spain · Bentifen, Ketisal
    • Finland · Ketazed, Ketotifen Stulln 0,25 Mg/Ml Silmätipat, Liuos
    • France · Ketazed, Monoketo
    • United Kingdom (Northern Ireland) · Ketazed, Ketofall
    • Greece · Cleroptic, K-Drops
    • Ireland · Ketofall, Zaditen
    • Iceland · Zaditen
    • Italy · Brunistill, Chetotifene Mylan Generics
    • Luxembourg · Altriabak, Ketazed
    • Latvia · Ketotifen
    • Netherlands · Altriabak, Ketazed
    • Norway · Ketazed, Zaditen
    • Portugal · Lidina, Lidinafree
    • Romania · Ketazed, Ketof
    • Sweden · Bentifen, Ketazed
    • Slovenia · Zaditen, Zaditen Sdu
    • Slovakia · Denerel, Zaditen

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/3083ad0b-a190-4298-b063-481a3a25a151
GET /v1/drugs/3083ad0b-a190-4298-b063-481a3a25a151?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Syrop",
  "source": "urpl",
  "strength": "1 mg/5 ml",
  "packaging": "05909990458813 ¦ Rp ¦ 44173\n1 butelka 100 ml",
  "substance": "Ketotifeni hydrofumaras 1.38 mg",
  "common_name": "Ketotifenum",
  "pl_product_id": "100091241",
  "pozwolenie_nr": "04588",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about ketotifen.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console